Biohope presents TRANSBIO clinical study results at ESOT Congress 2019
Biohope validated its product IMMUNOBIOGRAM® (IMBG) in [...]
Startups in Europe 2019
Biohope recognized by STARTUP CITY Magazine as one of [...]
Horizon Magazine interviews Dra. Portero
To help prevent organ rejection, transplant recipients [...]
Successful completion of TRANSBIO clinical study
Biohope, an R&D company dedicated to the developme [...]
Biohope at BIO International Convention
Ricardo Brage (Business Development Director) and Fran [...]
Biohope Poster awarded at 2019 ATC
Our CEO Isabel Portero and medical director Teresa Díe [...]
Interview with Isabel Portero in Radio.
Isabel Portero was invited to the radio program "Más y [...]
Biohope invited to the Technical Investment Conference in Paris
The global objective of this conference is the promot [...]
Isabel Portero invited to the European Commission Investor Day
Isabel Portero, CEO of Biohope, participates in this [...]
Biohope in Tech Demo Day ´19
La Salle Tecnova, one of the most important incubator [...]